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There is a large market for blood pressure measuring
devices not only in clinical medicine but also among
the public where the demand for self measurement of
blood pressure is growing rapidly. For consumers,
whether medical or lay, accuracy should be of prime
importance when selecting a device to measure blood
pressure. However, most devices have not been
evaluated for accuracy independently using the two
most widely used protocols: the British Hypertension
Society (BHS) protocol and the standard set by the US
Association for the Advancement of Medical Instru›
mentation (AAMI).1 2 The Working Group on Blood
Pressure Monitoring of the European Society of
Hypertension has decided to review blood pressure
measuring devices regularly to guide purchasers.3 For
this first report devices for which there is published
evidence of independent validation using these proto›
cols have been surveyed. Because most blood pressure
devices have not been independently validated, only a
fraction of the many devices available have been
surveyed. Devices that have been validated recently for
which results have not yet been published were not
included, but this shortcoming should be addressed in
future.
Methods
Validation standards
In 1987, the American Association for the Advance›
ment of Medical Instrumentation published a
standard for sphygmomanometers which included a
protocol for evaluating the accuracy of devices.4 In
1990 a protocol was devised by the British
Hypertension Society.5 Both protocols have since
been revised.1 2 Since the two protocols can be recon›
ciled the joint criteria are applied in most validation
studies.6 The criteria for fulfilling the BHS protocol
are that devices must achieve at least grade B (where A
denotes greatest agreement with mercury standard
and D denotes least agreement) for systolic and for
diastolic pressures (table 1)1; the criteria for fulfilling
the AAMI protocol are that the test device must not
differ from the mercury standard by a mean difference
> 5 mm Hg or a standard deviation > 8 mm Hg.2
Criteria for recommendation
The following criteria have been used to designate
devices according to accuracy. A device is classed as
recommended if it fulfils the AAMI criteria for both
systolic and diastolic pressures (denoted as passed) and
received a grade of A or B under the BHS protocol for
both systolic and diastolic blood pressures. A device is
not recommended if it fails the AAMI criteria for either
systolic or diastolic pressure and achieves a grade of C
or D for either systolic or diastolic pressure under the
BHS protocol. A questionable recommendation is
made when there is doubt about the strength of
evidence. This may occur when a device fulfils the
criteria of one protocol but not the other, and it may be
best not to recommend the device for clinical use until
a confirmatory study has been performed; when the
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Summary points
Two manual sphygmomanometers have been
validated, one is recommended
Five devices for clinical use in hospitals have been
validated, two are recommended
23 devices for self measurement of blood
pressure have been validated, five are
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Table 1 Grading criteria used by the British Society of
Hypertension.1 Grades represent the cumulative percentage of
readings falling within 5 mm Hg, 10 mm Hg, and 15 mm Hg of
the mercury standard. All three percentages must be greater
than or equal to the values shown for a specific grade to be
awarded. Values are mm Hg
Absolute difference between standard and test device (%)
Grade <5 <10 <15
A 60 85 95
B 50 75 90
C 40 65 85
D Worse than C
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validation results were presented only in an abstract
without sufficient detail to appraise the methodology,
and it may be best to withhold an opinion until the full
results have been published or at least provided to a
potential purchaser by the manufacturer; when the
conditions of the protocols have not been fully
adhered to (listed as a protocol violation in our
scheme); or when a device fulfils the AAMI criteria for
intra›arterial validation (the BHS protocol does not
advocate validation using direct intra›arterial measure›
ment1), but it may be best to await a validation against
indirect blood pressure measurement before recom›
mending the device for general clinical use.
Identification of devices
This review was based on two previous surveys (which
should be consulted for early validation studies that are
not reproduced in this review),7 8 and computerised
search programs were used to identify validation stud›
ies in the literature published up to December 1999.
Blood pressure measuring devices were divided into
two broad categories: manual sphygmomanometers,
which include mercury and anaeroid devices; and
automated sphygmomanometers, which include
devices for clinical use in hospitals, for self measure›
ment of blood pressure, for ambulatory blood pressure
measurement, and for measuring blood pressure in
community settings. (Information on manufacturers
appears on the BMJ ’s website.)
Results
Manual sphygmomanometers
These devices are listed in table 2 .9–12 One model of the
many mercury sphygmomanometers available, the
PyMah (PyMah Corporation, Flemington, NJ), has
been validated according to both protocols and is rec›
ommended.9 Because mercury sphygmomanometers
are generally of a simple basic design with standard
components, it is probably reasonable to assume that
most would be of similar accuracy. The standard anaer›
oid sphygmomanometer has only been formally
validated according to the calibration procedure of the
BHS protocol,12 and the results support reservations
about anaeroid devices because they are susceptible to
becoming inaccurate without this being apparent to
the user.13
Automated sphygmomanometers
Devices for use in hospitals
Devices for clinical use in hospitals are listed in
table 3.14–18
Devices for self measurement of blood pressure
There are a large number of automated devices for self
measurement of blood pressure, virtually all of which
use the oscillometric technique. Formerly these devices
used automated inflation and deflation of a cuff
applied to the upper arm over the brachial artery.
Recently this technique has been used to measure
blood pressure over the radial artery at the wrist, but
since these devices become inaccurate if the arm is not
kept at heart level during measurement, the working
group is reluctant to recommend them regardless of
accuracy.19 Devices that measure blood pressure by
occluding a digital artery in the finger are also
available, but because the problem of limb position is
even more critical and there is the additional problem
of peripheral vasoconstriction affecting accuracy, this
technique is no longer recommended. These devices
have not been considered in this review.19
Automated devices for upper arm measurement
are shown in table 4.9 20–29 Automated devices for wrist
measurement are listed in table 5.29–32 These have been
validated against brachial arterial measurements.
Devices for ambulatory measurement of blood pressure
There are two techniques for measuring ambulatory
blood pressure: the commonly used method of
intermittent measurement over 24 hours and the
developing method of continuous waveform analysis.
Intermittent measurement—Devices dependent on
intermittent measurement are listed in table 6.33–68
Many of these devices have been validated for use in
specific groups, such as elderly people and pregnant
women, and in differing circumstances, such as during
exercise and in different postures. Validating devices
for use in ambulatory conditions presents many meth›
odological difficulties, and some evidence suggests that
inaccuracies found during static conditions may be
amplified in ambulatory conditions.69
Devices for continuous non›invasive blood pressure
monitoring of a finger—The Portapres (TNO, Amster›
dam), a portable recorder for 24 hour ambulatory
monitoring, can provide beat to beat monitoring which
Table 2 Manual blood pressure measuring devices validated using the protocols of the
Association for the Advancement of Medical Instrumentation and the British
Hypertension Society
Device
Protocol
Use RecommendationAAMI*
BHS (systolic/
diastolic)†
PyMah mercury9 Passed A/A At rest Recommended
Hawksley RZS (US model)10, 11 Failed B/D At rest Not recommended
Hawksley RZS (UK model) 10, 11 Failed C/D At rest Not recommended
Aneroid device12 NA Failed At rest; only
abstract available
Questionable
recommendation
AAMI=Association for the Advancement of Medical Instrumentation; BHS=British Hypertension Society;
RZS=random zero sphygmomanometer; NA=not applied.
*To meet AAMI criteria the mean difference between the device and the mercury standard must be
<5 mm Hg or the standard deviation must be <8 mm Hg.
†To meet BHS criteria devices must achieve a grade of at least B for both systolic and diastolic
measurements. Grade A denotes greatest agreement with mercury standard and D denotes least agreement.
Table 3 Automated blood pressure measuring devices for clinical use in hospitals
validated using the protocols of the Association for the Advancement of Medical
Instrumentation and the British Hypertension Society. Devices were validated in
oscillometric mode unless otherwise indicated
Device
Protocol
Use RecommendationAAMI*
BHS (systolic/
diastolic)†
Datascope Accutorr Plus17 Passed A/A At rest Recommended
CAS Model 901018 Passed NA At rest in adults Recommended
In neonates Recommended
Tensionic Mod EPS 11218 Passed B/A At rest; only
abstract available
Questionable
recommendation
Colin Pilot 920019
(tonometric mode)
Passed NA At rest;
intra›arterial
Questionable
recommendation
Dinamap 810020, 21 Failed B/D At rest Not recommended
AAMI=Association for the Advancement of Medical Instrumentation; BHS=British Hypertension Society;
NA=not applied.
*To meet AAMI criteria the mean difference between the device and the mercury standard must be
<5 mm Hg or the standard deviation must be <8 mm Hg.
†To meet BHS criteria devices must achieve a grade of at least B for both systolic and diastolic
measurements. Grade A denotes greatest agreement with mercury standard and D denotes least agreement.
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gives waveform measurements similar to intra›arterial
recordings. However, the technique is subject to
various inaccuracies, which the use of correction
factors and digital filters in the latest model may
remove; this model is awaiting formal validation.70 71
Devices for measuring blood pressure in a community
setting
There is little information available on the accuracy of
automated devices that are installed in public retail
areas—such as pharmacies, supermarkets, health
clinics, and companies in a variety of industries—which
permit the public to measure blood pressure without
charge in an unsupervised, crowded setting with high
ambient noise. Evaluations of one such device, the Vita
Stat 90550 (Spacelabs Medical, Redmond, WA), have
had conflicting results.72 73
Discussion
Manufacturers of blood pressure measuring devices
use innovative technology to provide an array of
systems that can analyse, store, and display features of
a haemodynamic variable in ways that would have
been beyond the dreams of the pioneers of the
technique. Although the selection of a blood pressure
measuring device may be influenced by many factors, a
fundamental requirement must be that it gives
accurate measurements; too often accuracy has been
sacrificed for technological ingenuity.
The evidence from validation studies is accumulat›
ing, and devices are being scrutinised more critically;
this has been the case with ambulatory devices used in
specific populations, such as in children, elderly
people, and pregnant women. However, the evidence is
not always clear cut. There may have been protocol
violations; the data published may have been
inadequate, such as sometimes occurs when only
abstracts have been published; and there may be dis›
agreement between validation studies of the same
device. None the less certain recommendations can be
made to assist potential purchasers.
In interpreting the recommendations made by this
survey the following factors should be considered. A
device fulfilling the AAMI criteria and graded A or B
for both systolic and diastolic pressure under the BHS
protocol has been recommended on grounds of accu›
racy without equivocation; one that fails the AAMI
protocol for either systolic or diastolic pressure and
has a grade of C or D for either systolic or diastolic
pressure under the BHS protocol cannot be recom›
mended on the grounds of accuracy. Devices are given
a questionable recommendation if there is an element
of doubt in interpreting the results of a validation
study. One circumstance that a purchaser should also
consider, but for which we cannot make a recommen›
dation, is the occasional conflict that arises when a
device fulfils the criteria of the protocols when
validated at one centre but not another. When this
occurs the details of the methodology may need to be
scrutinised to determine if differences in the selection
of participants, for example, might explain the conflict;
it may be best to await the results of a confirmatory
study before deciding whether the device is accurate.
Only a fraction of the devices available worldwide
have been independently validated. This is especially
true of devices used for self measurement . In 1994, Ng
and Small surveyed 423 automated devices, of which
161 were designed for self measurement.74 Since then
the number of devices available for self measurement
has increased greatly but comparatively few have been
validated. The situation is even worse for automated
devices designed for use in specialised areas of hospitals,
such as operating theatres and intensive care units,
where accuracy should be a priority. Only five of the
Table 4 Automated blood pressure measuring devices for self measurement at the
upper arm validated using the protocols of the Association for the Advancement of
Medical Instrumentation and the British Hypertension Society. For the first seven
devices grading criteria had not been established although the British protocol was in
use.13 Devices were validated in oscillometric mode unless otherwise indicated
Device
Protocol
Use RecommendationAAMI*
BHS
(systolic/
diastolic)†
Omron HEM›400C9 Failed Failed At rest Not recommended
Philips HP5308 (auscultatory
mode)9
Failed Failed At rest Not recommended
Philips HP5306/B9 Failed Failed At rest Not recommended
Healthcheck CX›5 0600209 Failed Failed At rest Not recommended
Nissei analogue monitor
(auscultatory mode)9
Failed Failed At rest Not recommended
Systema Dr MI›1509 Failed Failed At rest Not recommended
Fortec Dr MI›1009 Failed Failed At rest Not recommended
Philips HP533220 Failed C/A At rest Not recommended
Nissei DS›17520 Failed D/A At rest Not recommended
Omron HEM›705CP20 Passed B/A At rest Recommended
Omron HEM›70621 Passed B/C At rest Not recommended
Omron HEM›403C22 Failed C/C Protocol violation Not recommended
Omron HEM›703CP23 Passed NA Intra›arterial Questionable
recommendation
Omron M424 Passed A/A Only abstract available;
details missing
Questionable
recommendation
Omron MX224 Passed A/A Only abstract available;
details missing
Questionable
recommendation
Omron HEM›722C25 NA A/A Protocol violation Questionable
recommendation
Omron HEM›722C26 Passed A/A At rest in elderly people Recommended
Omron HEM›735C26 Passed B/A At rest in elderly people Recommended
Omron HEM›713C27 Passed B/B At rest Recommended
Omron HEM›737 Intellisense28 Passed B/B At rest Recommended
Visomat OZ229 Passed C/B At rest Not recommended
AAMI=Association for the Advancement of Medical Instrumentation; BHS=British Hypertension Society;
NA=not applied.
*To meet AAMI criteria the mean difference between the device and the mercury standard must be
<5 mm Hg or the standard deviation must be <8 mm Hg.
†To meet BHS criteria devices must achieve a grade of at least B for both systolic and diastolic
measurements. Grade A denotes greatest agreement with mercury standard and D denotes least agreement.
Table 5 Automated blood pressure measuring devices for self measurement at the
wrist validated using the protocols of the Association for the Advancement of Medical
Instrumentation and the British Hypertension Society
Device
Protocol
Use RecommendationAAMI*
BHS
(systolic/
diastolic)†
Omron R330 NA NA Intra›arterial comparison Questionable
recommendation
Omron R329 Failed D/D At rest Not recommended
Boso›Mediwatch31 NA C/C At rest; protocol violation Not recommended
Omron Rx32 Failed B/B At rest; only abstract available Questionable
recommendation
AAMI=Association for the Advancement of Medical Instrumentation; BHS=British Hypertension Society;
NA=not applied.
*To meet AAMI criteria the mean difference between the device and the mercury standard must be <5 mm
Hg or the standard deviation must be <8 mm Hg.
†To meet BHS criteria devices must achieve a grade of at least B for both systolic and diastolic
measurements. Grade A denotes greatest agreement with mercury standard and D denotes least agreement.
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hundreds of devices available have been validated using
the two protocols, of which only two met the criteria for
recommendation in this review.8 75 The much used
anaeroid sphygmomanometer has only recently been
independently evaluated.12 However, because these
devices become inaccurate with use without this inaccu›
racy being apparent to the user, it is also necessary to
validate them after they have been used for some time.13
Table 6 Ambulatory blood pressure measuring devices validated using the protocols of the Association for the Advancement of
Medical Instrumentation and the British Hypertension Society
Device Mode
Protocol
Use RecommendationAAMI*
BHS (systolic/
diastolic)†
Accutracker II (30/23)33 Auscultatory Passed A/C At rest Not recommended
CH›DRUCK34 Auscultatory Passed A/A At rest Recommended
Daypress 50035 Oscillometric Passed A/B At rest Recommended
DIASYS 20036 Auscultatory Passed C/C At rest Not recommended
DIASYS Integra37 Auscultatory Passed B/A At rest Recommended
Oscillometric Passed B/B At rest Recommended
ES›H53138 Auscultatory Passed A/A At rest Recommended
Oscillometric Passed B/B At rest Recommended
Medilog ABP39 Auscultatory Passed NA At rest Questionable
recommendation
Meditech ABPM›0440 Oscillometric Passed B/B At rest Recommended
Nissei DS›24041 Oscillometric Passed B/A Only abstract available; details
missing
Questionable
recommendation
OSCILL›IT42 Oscillometric Passed C/B At rest Not recommended
Pressurometer IV43 Auscultatory Failed C/D At rest Not recommended
Profilomat44 Auscultatory Passed B/A At rest Recommended
Profilomat45 Auscultatory Passed B/C In pregnancy Not recommended
Profilomat II46 Oscillometric Failed C/B At rest Not recommended
QuietTrak 47 Auscultatory Passed B/B At rest Recommended
QuietTrak48 Auscultatory Passed B/B At rest; only abstract Questionable
recommendation
QuietTrak49 Auscultatory Failed D/D In pre›eclampsia Not recommended
QuietTrak50 Auscultatory Failed B/B In pregnancy Not recommended
QuietTrak51 Auscultatory Passed
A/A At rest Recommended
A/A During exercise Recommended
A/A Different postures Recommended
A/A In elderly people Recommended
A/A In children Recommended
A/A In pregnancy Recommended
Save 33, Model 252 Oscillometric Passed B/B At rest Recommended
Schiller BR›10253 Auscultatory Passed B/B At rest Recommended
Oscillometric Failed D/B At rest Not recommended
SpaceLabs 9020254 Oscillometric Passed B/B At rest Recommended
SpaceLabs 9020755 Oscillometric Passed B/B At rest Recommended
SpaceLabs 9020756 Oscillometric Passed A/C In pregnancy Not recommended
SpaceLabs 9020757 Oscillometric Passed B/B In pregnancy Recommended
SpaceLabs 9020745 Oscillometric Passed B/C In pregnancy Not recommended
SpaceLabs 9020749 Oscillometric Failed D/D In pre›eclampsia Not recommended
SpaceLabs 9020758 Oscillometric Passed C/C In pre›eclampsia Not recommended
SpaceLabs 9020759 Oscillometric SBP Pass C In children Not recommended
SpaceLabs 9020759 DBP Fail D In children Not recommended
SpaceLabs 9020760 Oscillometric Passed B/A Elderly people standing and sitting
(SBP <160 mmHg)
Recommended
SpaceLabs 9020760 Oscillometric Passed D/A Elderly people supine; tested at all
pressures
Not recommended
SpaceLabs 9020761 Oscillometric Passed C/B During haemodialysis Not recommended
SpaceLabs 9021762 Oscillometric Passed A/A At rest Recommended
TM›2420/TM›202063 Oscillometric Failed D/D At rest Not recommended
TM›2420 Model 664 Oscillometric Passed B/B At rest Recommended
TM›2420 Model 765 Oscillometric Passed B/B At rest Recommended
TM›242166 Oscillometric Passed B/A At rest Recommended
TM›242167 Oscillometric NA
A/B In children aged 7›8 years sitting Questionable
recommendation
A/B In children of all ages sitting Questionable
recommendation
TM›242167 Auscultatory NA C/C In children in different postures Not recommended
Takeda 243068 Oscillometric Passed A/A At rest Recommended
AAMI=Association for the Advancement of Medical Instrumentation; BHS=British Hypertension Society; NA=not applied; SBP=systolic blood pressure; DBP=diastolic
blood pressure.
*To meet AAMI criteria the mean difference between the device and the mercury standard must be <5 mm Hg or the standard deviation must be <8 mm Hg.
†To meet BHS criteria devices must achieve a grade of at least B for both systolic and diastolic measurements. Grade A denotes greatest agreement with mercury
standard and D denotes least agreement.
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A serious dilemma is how to influence manufactur›
ers to modify devices that have been shown to be inac›
curate. The Dinamap Portable Monitor model 8100
(Critikon, Tampa, FL) is an example of this: despite a
number of reports of inaccuracy18 76 it is one of the
most popular automated devices used in clinical prac›
tice and hypertension research. It seems that purchas›
ers and users of expensive devices for blood pressure
measurement in specialised hospital areas are pre›
pared to accept the word of manufacturers with regard
to their accuracy and performance and to ignore
warnings from the scientific literature as to their short›
comings.
Again, the situation is worse for self measurement
devices. Despite the poor accuracy record of devices
that measure blood pressure at the wrist and the
serious misgivings voiced by clinicians about these
devices,19 their popularity is growing. In Germany, for
example, 1.2 million self measurement devices are sold
annually.30
The European Union and international organisa›
tions of specialists in hypertension have unanimously
recommended that all devices for measuring blood
pressure should be independently validated.19 77–82 The
reality is, however, that most devices are not validated
independently. This may be partly due to the expense
of conducting validation studies using complex proto›
cols.1 2 Recently, the European Society of Hypertension
Working Party on Blood Pressure Monitoring agreed
proposals to simplify the BHS protocol without
compromising the integrity of the procedures, and an
international protocol for validation is being drafted.83
This will help manufacturers to market devices world›
wide, expedite validation procedures, reduce the
expense of performing studies, and permit more
centres to undertake validation procedures; all of
which would enable manufacturers to have all devices
validated independently before they are marketed.
Early publication of validation studies might further
encourage manufacturers to have their devices
evaluated, and the readiness of Blood Pressure Monitor›
ing to act as a repository of peer reviewed studies is
welcomed. The internet might provide a means of con›
tinuously updating information on blood pressure
measuring devices.
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Endpiece
Importance of compassion
A traditional Chinese doctor is instructing his
apprentice: “He said that knowledge was of little
use without wisdom, and that there was no wisdom
without spirituality, and that true spirituality always
included service to others. As he explained many
times, the essence of a good physician consisted of
a capacity for compassion and a sense of the
ethical, without which qualities the sacred art of
healing degenerated into simple charlatanism.”
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